Similar Papers

Paper Title
Journal
Date
Author
PO.5.97 The renal activity index for lupus (RAIL) identifies active renal disease in SLE patients and its longitudinal score associates with renal responses in lupus nephritis
C Lindholm ... F Jones
Lupus Science & Medicine | VOL. 9
C Lindholm, et. al.C Lindholm ... F Jones
27 Sep 2022
Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria.
Hanni Menn-Josephy ... Vanessa Birardi
Clinical journal of the American Society of Nephrology : CJASN | VOL. 19
Hanni Menn-Josephy, et. al.Hanni Menn-Josephy ... Vanessa Birardi
18 Dec 2023
Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Subodh Gururani ... Megha Uppin
Lupus | VOL. 30
Subodh Gururani, et. al.Subodh Gururani ... Megha Uppin
26 Jul 2021
PO.5.107 Real-world clinical response of tacrolimus treatment in patients with lupus nephritis
C Suh ... J Kim
Lupus Science & Medicine | VOL. 9
C Suh, et. al.C Suh ... J Kim
27 Sep 2022
View more papers

More From: Lupus Science & Medicine

Paper Title
Journal
Date
Author
Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
Huqun Li ... Cuilian Guo
Lupus Science & Medicine | VOL. 12
Huqun Li, et. al.Huqun Li ... Cuilian Guo
09 Jan 2025
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus
Sinem Durmus ... Ozgur Kasapcopur
Lupus Science & Medicine | VOL. 12
Sinem Durmus, et. al.Sinem Durmus ... Ozgur Kasapcopur
08 Jan 2025
Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA
Jessica Nicole Williams ... Sung Sam Lim
Lupus Science & Medicine | VOL. 12
Jessica Nicole Williams, et. al.Jessica Nicole Williams ... Sung Sam Lim
01 Jan 2025
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Yiting Chen ... Fei Han
Lupus Science & Medicine | VOL. 12
Yiting Chen, et. al.Yiting Chen ... Fei Han
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.